Product analyses reveal a troubling reality in the functional mushroom supplement market: between 30–60% of commercial mushroom products consist of rice starch filler, with bioactive compounds present only in trace amounts. This quality gap directly undermines marketed health claims and raises questions about product efficacy. Only Turkey Tail mushroom extract containing polysaccharide-K (PSK) has demonstrated robust clinical evidence, backed by four decades of use in Japanese oncology protocols and Cochrane-reviewed survival data. The disparity between PSK’s standardized formulation and the variable quality of other mushroom supplements reflects a broader regulatory challenge in the supplement industry. For healthcare providers and informed consumers, scrutinizing product labels for bioactive concentration percentages and third-party verification is increasingly critical.
Was this article helpful?
GMJ Brief · Key Finding
📰 Read the full article: Functional Mushrooms: What the Evidence Actually Shows →
